Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
1.450
+0.060 (4.32%)
At close: May 9, 2025, 4:00 PM
1.450
0.00 (0.00%)
After-hours: May 9, 2025, 7:00 PM EDT
Editas Medicine Employees
Editas Medicine had 246 employees as of December 31, 2024. The number of employees decreased by 19 or -7.17% compared to the previous year.
Employees
246
Change (1Y)
-19
Growth (1Y)
-7.17%
Revenue / Employee
$131,358
Profits / Employee
-$963,793
Market Cap
121.38M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
EDIT News
- 4 days ago - Editas Medicine to Announce First Quarter 2025 Financial Results and to Participate in Investor Conference in May - GlobeNewsWire
- 11 days ago - Editas Medicine to Present Preclinical Data Demonstrating Progress in the Development of an in vivo Gene Editing Pipeline at the American Society of Gene and Cell Therapy Annual Meeting - GlobeNewsWire
- 7 weeks ago - Editas Medicine Announces Chief Financial Officer Transition - GlobeNewsWire
- 2 months ago - Editas Medicine, Inc. (EDIT) Barclays 27th Annual Global Healthcare Conference (Transcript) - Seeking Alpha
- 2 months ago - Editas Medicine, Inc. (EDIT) Leerink Partners Global Healthcare Conference (Transcript) - Seeking Alpha
- 2 months ago - Editas Medicine Announces Fourth Quarter and Full Year 2024 Results and Business Updates - GlobeNewsWire
- 2 months ago - Editas Medicine, Inc. (EDIT) TD Cowen 45th Annual Health Care Conference Transcript - Seeking Alpha
- 2 months ago - Editas Medicine to Announce Fourth Quarter/Full Year 2024 Financial Results and to Participate in Investor Conferences in March - GlobeNewsWire